In this work, we looked at the levels of miR-21 and miR-34a in parallel to Bcl-2, BRCA1, BRCA2, and p53 in female BC patients before and after chemotherapy to evaluate how they responded to the chemotherapy treatment. This evidence concerns the gene TP53 and breast cancer.